Elsevier's Arezzo Puts GPs at the Vanguard of Improved Cancer Diagnosis

ElsevierElsevier, a world-leading provider of scientific, technical, and medical information products and services, is now able to support primary care clinicians and others to deliver high quality care in areas such as cancer diagnoses, referral rates and self-care through Arezzo, its active clinical decision support (CDS) technology. The product will be on show at EHI Live 2015, the UK's largest digital health event, 3rd to 4th November.

Arezzo is an active CDS inference engine. By integrating with clinical systems, Arezzo matches appropriate evidence-based guidelines with patient information and dynamically evaluates best practice options in light of the current patient and disease information.

Robert Dunlop, clinical director of Elsevier Clinical Solutions, will demonstrate how Arezzo Pathways can be used to implement the latest NICE guidelines for early cancer diagnosis and so address issues over increased mortality rates reported in a recent study published in the British Medical Journal. In addition Dunlop will highlight how Arezzo has been proven to help improve the use of similar protocols in the treatment of stroke in New Zealand. His talk will be part of the Digital Primary Care conference track, which Elsevier is sponsoring.

"CDS should make the right thing to do, the easy thing to do. Yet in reality not all such systems deliver improved patient outcomes, and can prove an obstacle to better care. With Arezzo, it can be shown that putting active evidence-based guidelines in the hands of GPs directly at the point of care can help improve clinical practice," Dunlop said.

Arezzo can help GPs make a cancer diagnosis much more quickly and with much more confidence by applying the latest NICE recommendations to an individual patient’s symptoms. It can also perform a 'safety-netting' function so that patients with vague symptoms are flagged for follow up. Early diagnosis can help improve chances of cancer survival, and missed diagnoses are a real concern for the clinical community.

Dunlop will also show how that, by using such technology to provide the right individual with the right information in ways that make most sense, evidence-based advice can be used across the patient journey to deliver responsive, effective and personalised care.

British GPs can now benefit from the same technology, which is in use in more than 1,000 GP practices in New Zealand. Arezzo was shown to have halved the number of hospital admissions for childhood asthma in one trial in the country, and has helped increase the use of clinical guidelines for stroke patients by delivering evidence-based content at the point of care.

Arezzo supports clinicians by identifying the optimal treatment path specific to each patient, and matching the appropriate evidence-based guidelines with patient information to provide a number of best practice recommendations for the clinician to choose from. This innovative use of computer-interpretable guidelines has a proven track record across multiple care settings, from patient self-care advice via online health and symptom checkers through to telephone triage services.

Greater self-care, increased role for primary care and more personalised services are at the heart of the NHS’ urgent and emergency care review. Central to this, and to wider policy initiatives, is the need to reduce the amount of unacceptable variation in clinical care that means that patients in one part of the country get different care to those elsewhere.

Enabling GPs to be at the vanguard of delivering better care for better value will be key themes at the Digital Primary Care conference track, which takes place on 3rd November as part of EHI Live. This conference track will also discuss the remote monitoring of patients, patient activation, asset and resource optimisation, and the need for patient information to be available digitally to all healthcare professionals. Speakers from NHS England will outline the next steps for digital primary care, and include Beverley Bryant, director of strategic systems and technology, Tracey Grainger, head of digital primary care development, and Indi Singh, head of enterprise architecture and interoperability champion.

EHI Live takes place on 3rd and 4th November 2015 at the NEC, Birmingham. Elsevier Clinical Solutions will be exhibiting at stand A74. Robert Dunlop will be speaking at 11.45 on 3rd November as part of the Digital Primary Care conference stream.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes more than 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...